GW Pharmaceuticals PLC Total Voting Rights (3413H)
November 30 2015 - 3:38AM
UK Regulatory
TIDMGWP
RNS Number : 3413H
GW Pharmaceuticals PLC
30 November 2015
GW Pharmaceuticals PLC ("GW Pharmaceuticals")
TOTAL ISSUED SHARE CAPITAL
Cambridge, UK, 30 November 2015: In accordance with the
requirements of the FCA's Disclosure and Transparency Rule 5.6.1,
GW Pharmaceuticals plc ("GW" or "the Company") (AIM:GWP,
NASDAQ:GWPH) confirms that the Company's issued share capital
consists of 261,180,173 ordinary shares of 0.1p each in issue, each
with equal voting rights. No shares are held in treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine whether they are
required to notify their interest, or a change to their interest,
in the Company under the FCA's Disclosure and Transparency
Rules.
For further information, please contact:
GW Pharmaceuticals PLC +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser)
James Steel/Oliver Jackson +44 (0) 20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRFMMFMLGRGKZG
(END) Dow Jones Newswires
November 30, 2015 04:38 ET (09:38 GMT)
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More GW Pharm. News Articles